Multidisciplinary Approach for Bone Metastasis: A Review
Top Cited Papers
Open Access
Abstract
Progress in cancer treatment has improved the survival of patients with advanced-stage cancers. Consequently, the clinical courses of patients are prolonged and often accompanied by morbidity due to bone metastases. Skeletal-related events (SREs), such as pathological fractures and spinal paralysis, cause impairment in activities of daily life and quality of life (QOL). To avoid serious SREs causing impairment in QOL and survival, early diagnosis and a prophylactic approach are required. It is necessary to initiate a bone management program concurrently with the initiation of cancer treatment to prevent complications of bone metastasis. In addition, the requirement of a multidisciplinary approach through a cancer board focusing on the management of bone metastases and involving a team of specialists in oncology, palliative care, radiotherapy, orthopedics, nuclear medicine, radiology, and physiatrists has been emphasized. In the cancer board, a strong focus is placed on the prevention of complications due to bone metastases and on reductions in the high morbidity, hospitalization rate, and overall costs associated with advanced-stage cancers. Recent reports suggest the usefulness of such approaches. The multidisciplinary approach through a cancer board would improve QOL and prognosis of patients, leading to new or continued systemic therapy for primary cancers.Keywords
This publication has 65 references indexed in Scilit:
- Survival analysis of patients with femoral metastasesJournal of Surgical Oncology, 2011
- Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrowJournal of Clinical Investigation, 2011
- Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind studyThe Lancet, 2011
- In Brief: Classifications in BriefClinical Orthopaedics and Related Research, 2010
- Survival differences among women with de novo stage IV and relapsed breast cancerAnnals of Oncology, 2010
- Prospective characterization of musculoskeletal symptoms in early stage breast cancer patients treated with aromatase inhibitorsBreast Cancer Research and Treatment, 2007
- Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to boneEndocrine-Related Cancer, 2005
- Hypercalcemia Associated with CancerNew England Journal of Medicine, 2005
- Mechanisms of Bone MetastasisNew England Journal of Medicine, 2004
- General Principles of External Beam Radiation Therapy for Skeletal MetastasesClinical Orthopaedics and Related Research, 2003